FFCP PHASE2:Hg19::chrX:71458802..71458891,-
From FANTOM5_SSTAR
Jump to: navigation, search
Short description: | p1@ERCC6L |
---|---|
Species: | Human (Homo sapiens) |
DPI dataset: | Robust |
TSS-like-by-RIKEN-classifier(Yes/No): | Yes |
DHS support(Yes/No): | Yes |
Description: | CAGE_peak_1_at_ERCC6L_5end |
Coexpression cluster: | C109_Reticulocytes_non_acute_Hodgkin_Burkitt_retinoblastoma_lymphoma |
Association with transcript: | 0bp_to_ENST00000373657, NM_017669, uc004eap.1, uc004eaq.1_5end |
EntrezGene: | ERCC6L |
HGNC: | 20794 |
UniProt: | B5MDQ0Q2NKX8 |
Genome view: | ZENBU |
View on UCSC genome browser
CAGE Expression
Sample | p1@ERCC6L |
---|
0
5
10
15
20
- Click each plot point to find sample in table
Ontology-based sample term enrichment analysis<b>Summary:</b>This analysis has been performed by utilizing wilcoxon rank sum test.When the number of associated cells/tissues are > n , randomly sampled n cells/tissues are used for P value calculation with rank sum test. this process are repeated several times, and the P values are averaged on the log space <br><b>Analyst:</b> Hideya Kawaji<br><br>link to source dataset<br>data
Ontology term | p-value | n |
---|---|---|
cancer | 5.45e-39 | 235 |
disease of cellular proliferation | 2.28e-38 | 239 |
organ system cancer | 8.59e-21 | 137 |
cell type cancer | 9.97e-18 | 143 |
hematologic cancer | 2.04e-17 | 51 |
immune system cancer | 2.04e-17 | 51 |
carcinoma | 7.67e-14 | 106 |
leukemia | 7.91e-13 | 39 |
myeloid leukemia | 7.62e-10 | 31 |
Showing 1 to 9 of 9 entries